Extracorporeal membrane oxygenation (ECMO) or extracorporeal life support (ECLS), is a treatment that uses a synthetic heart and/or lung to support the body when a patient’s own organs are no longer functioning at capacity. Typically used for critically ill adult or pediatric patients, ECMO has the ability to support the body for a long period of time to allow the patient’s heart and lungs to recover. However, its survival rate is 30-60%. ECMO is growing in popularity because of its technological advancements, which makes it easier to administer and more effective as a temporary life support treatment. Watch this webinar to learn more about ECMO, how to design a sustainable ECMO program, key considerations (including payment reimbursement) and where to access resources.
Part I with Bishoy Zakhary, MD, assistant professor of medicine at Oregon Health & Science University and chair of education for the Extracorporeal Life Support Organization
Part II with Elizabeth A. Moore, BSN, RN, MBA, associate director of the Heart and Vascular Center at the University of Iowa Healthcare
Original webinar date: January 28, 2020